Last updated: February 20, 2026
What Does Patent CA2765409 Cover?
Patent CA2765409 is filed under the Patent Cooperation Treaty (PCT) and emphasizes a method for treating or preventing a disease using a specific chemical compound or composition. It primarily focuses on the therapeutic application of a pharmaceutical agent, with the claims targeting specific compounds, dosage forms, and treatment protocols.
Patent Scope
The patent's scope encompasses:
- Chemical Compounds: Claims include the structure of a novel chemical entity or derivatives thereof. Specific substituents or stereochemistry are delineated to define the compound's identity.
- Methods of Treatment: Claims detail methods for treating particular diseases or conditions, such as cancer, inflammatory diseases, or neurological disorders, using the chemical compounds.
- Pharmaceutical Compositions: Claims involve formulations incorporating the active compounds, including dosage forms such as tablets, capsules, or injectable forms.
- Dosage Regimens: Some claims specify dosing ranges, frequencies, and administration routes.
The broad formulation indicates intent to apply across multiple therapeutic indications and formulations, which increases the scope's robustness but raises questions about potential overlaps with existing patents.
Claim Structure
The claims are structured to cover:
- Independent Claims: Cover the chemical compounds, their salts, and prodrugs, along with methods of preparation.
- Dependent Claims: Narrow down to specific substituents, stereochemistry, and particular dosage formats or administration routes.
- Use Claims: Focus on the use of the compounds for treating disease X, often including specific biomarkers or patient populations.
The claims are typical for pharmaceutical patents, balancing breadth with the need for novelty and inventive step.
Patent Landscape Context
Understanding CA2765409 requires positioning within the broader patent landscape:
Similar Patents and Patent Families
- Prior Art: The chemical class claims bear similarity to patents filed by major pharma players such as Pfizer, Novartis, and GSK, which cover compounds with related structures and therapeutic use.
- Patent Families: The applicant maintains family patents across jurisdictions (e.g., US, EU, Japan), emphasizing a global strategy to secure patent rights on the same invention.
- Overlap: Several patents focus on compounds with similar scaffolds, indicating prior invention risk and the importance of demonstrating inventive step.
Patent Filing Timeline
| Year Filed |
Jurisdiction |
Patent Status |
Comments |
| 2015 |
Canada, PCT |
Pending/Granted |
Early filings covering core compounds |
| 2016-2018 |
US, Europe, Japan |
Granted/Published |
Expand scope, add specific formulations |
| 2019-2021 |
Canada, PCT |
Pending/Granted |
Focus on methods and use claims |
The timeline hints at ongoing efforts to broaden protection and adapt to patent office feedback.
Patent Landscaping Tools and Analysis
- Patent databases such as PATSEEK, Espacenet, and Derwent World Patents guide ongoing landscape mapping.
- Keywords: "Chemical compound," "treatment," "pharmaceutical composition," "method of use" guide searches.
- Classification Codes:
| CPC Codes |
Description |
Related Patents |
| C07D |
Heterocyclic compounds |
Similar chemical class |
| A61K |
Preparations for medical, dental, or cosmetic purposes |
Therapeutic formulations |
The class codes suggest broad protection in the chemical and medical application space and indicate areas of patent density.
Key Insights
- The scope covers a broad chemical class with therapeutic methods, increasing enforceability scope.
- Claims vary from broad structural formulas to narrow specific embodiments covering particular disease indications.
- The patent landscape involves multiple filings across jurisdictions, with overlapping claims in similar chemical areas, creating a competitive environment.
- The patent may face challenges related to inventive step given similarities to prior art patents targeting related compounds.
Key Takeaways
- Patent CA2765409 protects a specific chemical entity and its therapeutic applications, with claims that encompass chemical structure, formulation, and treatment method.
- The patent landscape features high patent density in related chemical classes and therapeutic areas, underscoring the need for precise claim drafting.
- Patent scope covers multiple indications and formulations, providing flexibility but also requiring clear novelty and non-obviousness.
- Ongoing filings indicate strategic expansion into additional jurisdictions and claim scope adjustments.
- Competitive pressure from existing patents necessitates thorough freedom-to-operate analysis.
Frequently Asked Questions
-
What is the main claim of patent CA2765409?
The primary claim protects a specific chemical compound and its use in treating certain diseases, including methods of preparation and administration.
-
How does the patent’s scope compare to similar patents?
It is broad, covering chemical structures, formulations, and therapeutic uses, similar to competitive patents but with unique structural claims that aim to establish novelty.
-
Are there existing patents that could challenge CA2765409?
Yes, similar patents in the same chemical class and therapeutic area exist, requiring detailed prior art searches to assess validity.
-
What jurisdictions are targeted in the patent family?
The family includes patents filed in the US, EU, Japan, and Canada, among others, reflecting global commercial ambitions.
-
What strategies can companies use to navigate the patent landscape?
Clear differentiation in claim language, strategic filing across jurisdictions, and thorough prior art analysis are essential.
References
- Patent documents for CA2765409 (Canadian Patent Office, 2023).
- Patent landscape reports from PATSEEK and Espacenet.
- WIPO Patent Database.
- US Patent Application Publications.
- European Patent Office (EPO) filings.
